We further noticed that CD2AP and TRIM5 expressions in GBM samples were positively correlated using data from the GEPIA, CGGA, and Gravendeel datasets, though the coefficient values ranged between 0.489-0.65, implicating a moderate correlation between them (Supplementary Fig. S5D–F). This evidence concerns the gene TRIM5 and glioblastoma.